✦ LIBER ✦

Induction paclitaxel and carboplatin for patients with head and neck carcinoma : Analysis of 62 patients treated between 1994 and 1999

✍ Scribed by Frank R. Dunphy; Teresa L. Dunleavy; Bruce R. Harrison; Kathryn M. Trinkaus; Han J. Kim; Brendan C. Stack Jr.; Burton Needles; James H. Boyd

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 111 KB
Volume: 91
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20010301)91:5<940::aid-cncr1083>3.0.co;2-a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of induction chemotherapy

Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck

✍ Dong M. Shin; Bonnie S. Glisson; Fadlo R. Khuri; Scott M. Lippman; Lawrence Gins 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

## Abstract ## BACKGROUND This Phase II trial was conducted to determine the response rate, particularly of the primary sites, tolerability, and toxicity of induction chemotherapy of paclitaxel, ifosfamide, and carboplatin for patients with previously untreated locally advanced squamous cell carci

Phase II study of induction chemotherapy

Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck

✍ Robert Haddad; Marshall Posner 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB 👁 2 views

Phase II study of paclitaxel, ifosfamide

Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma

✍ Dong M. Shin; Fadlo R. Khuri; Bonnie S. Glisson; Lawrence Ginsberg; Vali M. Papa 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Tobacco use outcomes among patients with

Tobacco use outcomes among patients with head and neck carcinoma treated for nicotine dependence : A matched-pair analysis

✍ Yolanda I. Garces; Darrell R. Schroeder; Liza M. Nirelli; Gary A. Croghan; Ivana 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 1 views

## Abstract ## BACKGROUND The current study described tobacco use outcomes among patients with head and neck carcinoma who underwent treatment for nicotine dependence at the Mayo Clinic Nicotine Dependence Center (NDC; Rochester, MN). ## METHODS Using a 1:1 matched‐pair design, conditional logis

Paclitaxel, cisplatin, and 5-fluorouraci

Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck

✍ Maha Hussain; Shirish Gadgeel; Omer Kucuk; Wei Du; Walter Salwen; John Ensley 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 3 views

## BACKGROUND. The combination of cisplatin and 5-flurouracil (5-FU) is considered standard therapy for patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Paclitaxel has exhibited single-agent activity in patients with this disease. The authors conducted thi

Quality of life as a survival predictor

Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy

✍ Fu-Min Fang; Yi-Tien Liu; Yeh Tang; Chong-Jong Wang; Sheung-Fat Ko 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 1 views

## Abstract ## BACKGROUND Accumulating reports suggest that quality of life (QoL) may predict survival in patients with malignant disease. In the current study, the authors investigated if baseline QoL and changes in QoL during treatment were prognostic for patients with advanced head and neck squ